Red Violet, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Red Violet, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $90.25M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $75.19M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $60.20M | Feb 27, 2025 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $90.25M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $75.19M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $60.20M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $53.32M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $44.02M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $34.59M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $30.29M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $16.30M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $8.58M | Mar 7, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.15M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $7.00M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $13.53M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $616.0K | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $655.0K | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | ($6.81M) | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | ($11.08M) | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | ($6.87M) | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($21.50M) | Mar 7, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.14M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $7.92M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $2.50M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $361.0K | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($1.32M) | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | ($6.83M) | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | ($11.21M) | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | ($7.49M) | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($21.50M) | Mar 7, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.35M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $23.96M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $15.07M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $12.46M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $8.95M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $6.52M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $1.65M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | ($8.05M) | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | ($10.41M) | Mar 7, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $563.0K | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $169.0K | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $122.0K | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $373.0K | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $280.0K | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $154.0K | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $90.0K | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $90.0K | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $515.0K | Mar 7, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $112.01M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $98.53M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $92.99M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $77.41M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $74.38M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $51.99M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $48.87M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $39.83M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $25.13M | Mar 7, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.09M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $11.90M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $6.88M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $6.32M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $4.95M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $8.65M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $6.79M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $3.55M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $7.39M | Mar 7, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $100.93M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $86.63M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $86.11M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $71.09M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $69.43M | Mar 7, 2024 |
| FY2022 | Dec 31, 2020 | $43.35M | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | $42.08M | Mar 9, 2022 |
| FY2020 | Dec 31, 2018 | $36.28M | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | $17.74M | Mar 12, 2020 |
| FY2018 | Dec 31, 2016 | $15.22M | Mar 7, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.23M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $5.23M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $5.23M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $5.23M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $5.23M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $5.23M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $5.23M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $5.23M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $5.23M | Mar 7, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.28M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | ($870.0K) | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | ($7.87M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($21.40M) | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | ($22.02M) | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | ($22.67M) | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | ($15.86M) | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | ($4.78M) | Mar 12, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.56M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $36.50M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $32.03M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $31.81M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | $34.26M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $12.96M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $11.78M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $9.95M | Mar 12, 2020 |
| FY2018 | Dec 31, 2017 | $65.0K | Mar 7, 2019 |
| FY2018 | Dec 31, 2016 | $226.0K | Mar 7, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $0 | Mar 9, 2022 |
| FY2021 | Dec 31, 2020 | $1.70M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | $0 | Mar 10, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 9, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 9, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14.15M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | 13.94M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | 13.97M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 13.96M | Mar 7, 2024 |
| FY2022 | Dec 31, 2021 | 13.49M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | 12.17M | Mar 9, 2022 |
| FY2020 | Dec 31, 2019 | 11.55M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | 10.27M | Mar 12, 2020 |
| FY2019 | Dec 31, 2017 | 1,000 | Mar 12, 2020 |